ChemicalBook >> CAS DataBase List >>LDN-193189

LDN-193189

CAS No.
1062368-24-4
Chemical Name:
LDN-193189
Synonyms
LDN193189;CS-205;DM-3189;DM 3189;LDN193189(DM3189);LDN-193189, >=98%;LDN193189 free base;LDN-193189;LDN 193189;LDN193189 LDN193189 HCl;LDN-193189;LDN 193189;DM-3189;DM 3189
CBNumber:
CB22512071
Molecular Formula:
C25H22N6
Molecular Weight:
406.48
MDL Number:
MFCD17169988
MOL File:
1062368-24-4.mol
MSDS File:
SDS
Last updated:2023-05-18 11:31:16

LDN-193189 Properties

Density 1.33
storage temp. Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility H2O: soluble5mg/mL, clear (warmed)
form powder
pka 8.79±0.10(Predicted)
color yellow to orange
InChIKey XHBVYDAKJHETMP-UHFFFAOYSA-N
FDA UNII W69H5YQU9O

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
WGK Germany  3
HS Code  29339900

LDN-193189 price More Price(33)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML0559 LDN193189 hydrochloride ≥98% (HPLC) 1062368-24-4 5mg $130 2024-03-01 Buy
Sigma-Aldrich SML0559 LDN193189 hydrochloride ≥98% (HPLC) 1062368-24-4 25mg $522 2024-03-01 Buy
Cayman Chemical 11802 LDN-193189 ≥95% 1062368-24-4 1mg $35 2024-03-01 Buy
Cayman Chemical 11802 LDN-193189 ≥95% 1062368-24-4 5mg $96 2024-03-01 Buy
Cayman Chemical 11802 LDN-193189 ≥95% 1062368-24-4 10mg $140 2024-03-01 Buy
Product number Packaging Price Buy
SML0559 5mg $130 Buy
SML0559 25mg $522 Buy
11802 1mg $35 Buy
11802 5mg $96 Buy
11802 10mg $140 Buy

LDN-193189 Chemical Properties,Uses,Production

Description

Normal development and tissue repair are controlled in part by SMADs, a family of intracellular proteins that are activated by signaling via serine/threonine kinase receptors of the TGF-β superfamily. LDN-193189 inhibits SMAD1/5/8 phosphorylation by the bone morphogenetic protein (BMP) type I receptors, which are known as activin receptor-like kinases (ALKs), with an IC50 value of 4.9 nM. In in vitro kinase assays, it shows specificity for ALK1, 2, 3, and 6 (IC50s = 0.8, 0.8, 5.3, and 16.7 nM, respectively) over ALK4 and 5 (IC50s = 101 and 350 nM, respectively). LDN-193189 has been used to inhibit BMP type I receptor activity to study the pathogenesis of fibrodysplasia ossificans progressive, a congenital hyperossification disorder, and to examine the role of osteogenesis in prostate tumor metastases in bone.

Uses

4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline, is a selective inhibitor of bone morphogenetic protein (BMP) pathway, useful in the treatment of diseases. Potent BMP Inhibitor?, Promotes hPSC Neural Induction?.

Definition

ChEBI: 4-[6-[4-(1-piperazinyl)phenyl]-3-pyrazolo[1,5-a]pyrimidinyl]quinoline is a member of pyrimidines.

Biochem/physiol Actions

Although LDN193189 is a structural analog of dorsomorphin, these two drugs are found to establish different cellular responses. In vitro analysis reveals that LDN193189 inhibits a number of intracellular kinases such as, mitogen activated protein kinase 14 and 8 ( p38and c-Jun N-terminal kinase respectively), as well as those associated with AKT (serine/threonine kinase) and mTOR (mammalian target of rapamycin) signaling mechanisms. LDN193189 is known to elevate the levels hemoglobin and thus helps to prevent the onset of anemia of inflammation.

References

[1] yu pb, deng dy, lai cs, hong cc, cuny gd, bouxsein ml, hong dw, mcmanus pm, katagiri t, sachidanandan c, kamiya n, fukuda t, mishina y, peterson rt, bloch kd. bmp type i receptor inhibition reduces heterotopic [corrected] ossification. nat med. 2008 dec;14(12):1363-9.
[2] boergermann jh1, kopf j, yu pb, knaus p. dorsomorphin and ldn-193189 inhibit bmp-mediated smad, p38 and akt signalling in c2c12 cells. int j biochem cell biol. 2010 nov;42(11):1802-7.
[3] helbing t1, herold em, hornstein a, wintrich s, heinke j, grundmann s, patterson c, bode c, moser m. inhibition of bmp activity protects epithelial barrier function in lung injury. j pathol. 2013 sep;231(1):105-16. doi: 10.1002/path.4215. epub 2013 jul 10.

4363-93-3
1062368-24-4
Synthesis of LDN-193189 from 4-Quinolinecarboxaldehyde

LDN-193189 Preparation Products And Raw materials

Global( 154)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
Hubei Jusheng Technology Co.,Ltd.
18871490254 linda@hubeijusheng.com CHINA 28180 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 47465 58
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29627 58

View Lastest Price from LDN-193189 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine pictures 2020-01-09 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine
1062368-24-4
US $9.80 / KG 1g ≥99% 100kg Career Henan Chemical Co

LDN-193189 Spectrum

LDN193189 LDN193189 HCl 4-(6-(4-(piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline LDN193189(DM3189) 4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline DM 3189 DM-3189 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyriMidine LDN 193189(DM3189) 4-{6-[4-(piperazin-1-yl)phenyl]pyrazolo[ 4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline LDN 193189 LDN 193189 4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline 4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]-quinoline hydrochloride LDN-193189, >=98% 6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine USP/EP/BP Quinoline, 4-[6-[4-(1-piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]- LDN-193189, 98%, a selective BMP signaling inhibitor LDN193189 free base CS-205 LDN-193189;LDN 193189 LDN-193189;LDN 193189;DM-3189;DM 3189 LDN193189 1062368-24-4 C25H22N6 Smad TGF-beta Inhibitors TGF-beta/Smad